시퀀싱 시약 시장 규모, 점유율, 성장 분석 : 시약 유형별, 시퀀싱 기술별, 용도별, 최종사용자별, 지역별 - 업계 예측(2025-2032년)

Global Sequencing Reagents Market size was valued at USD 8.2 billion in 2023 and is poised to grow from USD 9.66 billion in 2024 to USD 35.82 billion by 2032, growing at a CAGR of 17.8% during the forecast period (2025-2032).

The global sequencing reagents market is poised for significant growth, driven by the increasing adoption of next-generation sequencing (NGS) technologies and the rising demand for precision medicine. As healthcare professionals increasingly utilize genomic data for various applications, including oncology and rare disease research, the demand for sequencing reagents is expected to surge. Moreover, the expanding use of genomic sequencing in agriculture, environmental monitoring, and microbiome studies presents new opportunities. Advances in technology are also leading to reduced sequencing costs and improved accessibility, further enhancing revenue prospects for providers. However, challenges such as high reagent costs, complex data analysis, ethical concerns, and compatibility issues with different platforms may hinder market penetration in the foreseeable future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Sequencing Reagents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Sequencing Reagents Market Segments Analysis

Global Sequencing Reagents Market is segmented by Reagent Type, Sequencing Technology, Application, End-User and region. Based on Reagent Type, the market is segmented into Library Preparation Kits, Template Kits, Control & Quality Assurance Kits, Sequencing Kits and Others (enrichment kits, indexing/barcoding reagents). Based on Sequencing Technology, the market is segmented into Next-Generation Sequencing (NGS), Sanger Sequencing and Third-Generation Sequencing (TGS) / Long-Read Sequencing. Based on Application, the market is segmented into Oncology & Liquid Biopsy, Reproductive Health / Prenatal Testing, Clinical Diagnostics, Research / Academic Genomics and Agriculture, Forensics & Others. Based on End-User, the market is segmented into Hospitals & Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Contract Research Organizations (CROs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Sequencing Reagents Market

One of the key market drivers for the global sequencing reagents market is the increasing demand for personalized medicine, which relies heavily on genomic data for tailored treatment approaches. As healthcare shifts towards precision medicine, the need for accurate and efficient sequencing technologies grows, prompting advancements in sequencing reagents. Additionally, the rising prevalence of genetic disorders and the expansion of applications in areas such as oncology, pharmacogenomics, and infectious disease management further fuel the market. These factors, combined with ongoing research and development initiatives, continue to enhance the capabilities and accessibility of sequencing reagents, driving their widespread adoption globally.

Restraints in the Global Sequencing Reagents Market

One significant market restraint in the global sequencing reagents market is the high cost associated with advanced sequencing technologies and the reagents themselves. The substantial financial investment required for research and clinical applications can deter smaller laboratories and institutions from adopting these technologies. Additionally, stringent regulatory requirements and the necessity for specialized personnel to effectively utilize sequencing reagents further complicate market entry for these entities. This high barrier to entry may limit innovation and access to cutting-edge sequencing solutions, ultimately slowing down the overall growth of the market and hindering widespread implementation across diverse research and clinical settings.

Market Trends of the Global Sequencing Reagents Market

The Global Sequencing Reagents market is witnessing a significant trend towards the expansion of single-cell and spatial genomics applications. Companies in the reagents sector are increasingly focusing on advancing barcoding chemistries and enhancing amplification efficiency, while also prioritizing contamination control to cater to the specialized demands of researchers. This shift is driven by the rising necessity for ultra-sensitive and low-input reagents capable of detecting subtle gene expressions and mutations, thereby enabling breakthroughs in personalized medicine and disease research. As a result, the market is poised for growth, with innovations in sequencing technologies shaping its future landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Sequencing Reagents Market Size by Reagent Type & CAGR (2025-2032)

• Market Overview
• Library Preparation Kits
• Template Kits
• Control & Quality Assurance Kits
• Sequencing Kits
• Others (enrichment kits, indexing/barcoding reagents)

Global Sequencing Reagents Market Size by Sequencing Technology & CAGR (2025-2032)

• Market Overview
• Next-Generation Sequencing (NGS)
• Sanger Sequencing
• Third-Generation Sequencing (TGS) / Long-Read Sequencing

Global Sequencing Reagents Market Size by Application & CAGR (2025-2032)

• Market Overview
• Oncology & Liquid Biopsy
• Reproductive Health / Prenatal Testing
• Clinical Diagnostics
• Research / Academic Genomics
• Agriculture, Forensics & Others

Global Sequencing Reagents Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinical Laboratories
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations (CROs)

Global Sequencing Reagents Market Size & CAGR (2025-2032)

• North America (Reagent Type, Sequencing Technology, Application, End-User)
  • US
  • Canada
• Europe (Reagent Type, Sequencing Technology, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Reagent Type, Sequencing Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Reagent Type, Sequencing Technology, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Reagent Type, Sequencing Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Illumina, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann La Roche AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina Cambridge Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ArcherDX, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing Genomics Institute (BGI)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations